Search Results

1-14 of 14 results for member:"Patsy Calton"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, what plans he has to increase the number of sign language interpreters for profoundly deaf people attending for NHS treatment.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 November 2004

Reference

196280; 426 c1693W;426 c1696W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, by what date internally-worn hearing aids will be fitted to all NHS patients for whom they are suitable and who request them.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

7 September 2004

Reference

424 c1077W; 186361

House

House of Commons

Adjournment debate

Westminster Hall adjournment debate on the NHS appointments system

Lead member

Patsy Calton

Answering member

Stephen Ladyman

Department

Department of Health

Type

Adjournment debates

Date

14 July 2004

Reference

423 c479-86WH

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, whether the Children's National Service Framework will reiterate the requirement for integrated paediatric continence services; and what action he will take following the publication of the Royal College of Nursing and Continence Foundation report, Is Policy Translated into Action; whether he requires...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

7 June 2004

Reference

422 c169W;422 c168W; 176048;176049

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what assessment he has made of the extent to which the recommendations in Circular HSC2001/016:LAC(2001)23 have been met by local authorities; and if he will make a statement. - Inc ref to 'Making Change Happen' (HC 514) 2002 103, copy in Library.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

27 January 2004

Reference

417 c326-7W; 150098

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what assessment he has made of the long-term effects of Ritalin.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

7 January 2004

Reference

145816; 416 c397W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many young people (a) under 11 and (b) over 11 have been prescribed Ritalin by a health authority in each of the last five years. - Inc table.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

18 December 2003

For answer on

7 January 2004

Answered on

7 January 2004

Mrs. Calton: To ask the Secretary of State for Health how many young people (a) under 11 and (b) over 11 have been prescribed Ritalin by a health authority in each of the last five years. [145815] Dr. Ladyman: Information is not available in the form requested. However the figures in the table following show the total number of prescription items of methylphenidate hydrochloride dispensed in the community in England in each of the last five years. The majority of prescription items of methylphenidate hydrochloride are for the brand Ritalin. Number of prescription items of methylphenidate hydrochloride dispensed in the community in England--1998 to 2002 Thousand _________________________________________________________________________________________________. Total 1998 126.6 1999 158.0 2000 186.2 2001 208.5 2002 254.0 _________________________________________________________________________________________________. Source: Prescription Cost Analysis data from the Prescription Pricing Authority In 2002, around 91 per cent. of the 254,000 prescription items were dispensed in the community to children (children under 16 and young people aged 16 to 18 in full time education). An estimated 1 per cent. of the items were dispensed to people aged 60 and over with the remainder being dispensed to other adults. These proportions have been similar in recent years.

Date

7 January 2004

Reference

145815; 416 c397W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what the average time was between diagnosis of a suspected haemorrhagic stroke and the administration of a CT scan in 2002-03. - This info is not collected centrally.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 November 2003

Reference

137347; 413 c579W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, whether his Department has completed an audit of whether the guidance Good Practice in Continence Services has improved paediatric continence services; what assessment his Department has made of how the Children's National Service Framework will improve services for children with continence problems;...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

14 October 2003

For answer on

20 October 2003

Answered on

20 October 2003

Mrs. Calton: To ask the Secretary of State for Health (1) whether his Department has completed an audit of whether the guidance "Good Practice in Continence Services" has improved paediatric continence services; [132876] (2) what assessment his Department has made of how the children's national service framework will improve services for children with continence problems; [132885] (3) what assessment his Department has made of how many children in England suffer from (a) nocturnal enuresis, (b) daytime wetting and (c) constipation and soiling. [132887] Dr. Ladyman: Good Practice in Continence Services was issued by the Department in April 2000 and provides guidance to primary care trusts (PCTs) on continence services. This includes that PCTs should have specialist continence services in place, which provide patients with an individual assessment of their needs. Provision of these services in England is a matter for PCTs, which are responsible for determining the level of services required to meet the needs of their local populations. The children's national service framework (NSF) will set out standards covering a broad range of services, including the management of common childhood conditions. Whilst few specific conditions will be covered, the standards are likely to cover what support should be available to children and their parents in managing a wide range of conditions and problems, including enuresis and soiling. The NSF will emphasise the promotion of evidence-based clinical guidelines and a number of examples of good practice in a range of different areas. Information on the prevalence of these common conditions in childhood is not collected centrally.

Date

20 October 2003

Reference

411 c466-7W;411 c470W; 132876;132885;132887

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what recent assessment he has made of unmet need with respect to child and adolescent mental health services, broken down by (a) region and (b)strategic health authority; and if he will make a statement. - Inc figures and fact that the information...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

15 July 2003

Reference

124921; 409 c230W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what measures are in place to prevent discrimination in the treatment of older people with breast cancer.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

10 July 2003

Reference

124372; 408 c1001W;408 c999W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what assessment he has made of the availability of hydrotherapy treatment for MS sufferers; and if he will make a statement. - Inc fact that we do not hold information centrally on the availability of these therapies.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

3 July 2003

Reference

122800; 408 c489W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many children under five years old have powered wheelchairs provided by the NHS; and if he will make a statement. - Includes table and fact that information is not held centrally.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

23 June 2003

Reference

120737; 407 c579W;407 c583W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans he has to expedite the review of (a) Seroxat and (b) other selective serotonin reuptake inhibitors; what plans he has to improve the warnings given to (a) prescribers and (b) the public about the (i) side-effects and (ii) withdrawal effects...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

12 June 2003

For answer on

20 June 2003

Answered on

20 June 2003

Mrs. Calton: To ask the Secretary of State for Health (1) what plans he has to expedite the review of (a) Seroxat and (b) other selective serotonin reuptake inhibitors; [119777] (2) what plans he has to improve the warnings given to (a) prescribers and (b) the public about the (i) side-effects and (ii) withdrawal effects of (A) Seroxat and (B) other selective serotonin reuptake inhibitors; [119778] (3) what plans he has to improve the effectiveness of the Yellow Card scheme for reporting adverse side- effects of drugs; [119779] (4) if he will withdraw Seroxat from use for new prescribing pending a review of its and other SSRI anti- depressants' safety. [119780] Dr. Ladyman: A new expert group of the Committee on Safety of Medicines (CSM) has been convened to further review the safety of selective serotonin re-uptake inhibitors (SSRIs) and to ensure the advice in the product information for both patients and prescribers is optimal for the safe use of these products. This group has been asked to examine what implications, if any, the CSM's recent advice on the use of Seroxat in children have for the use of Seroxat in adults and for other SSRIs. The timetable for the group's programme of work has been planned with a view to the availability of advice as promptly as possible, commensurate with a full and detailed consideration of the evidence including the experiences of patients. As part of its initial considerations, the group has advised on strengthened advice on side effects and withdrawal reactions for inclusion in the patient information leaflet on Seroxat. Product information for other SSRIs will also be considered. The advice of the CSM, most recently in 2001, is that the benefits of Seroxat, when used in adults for licensed indications, outweigh the risks. Regulatory authorities world-wide have also taken a similar position. Depression and anxiety disorders are serious conditions that can cause severe suffering and are associated with an increased risk of suicide. The availability of effective treatments is critically important. In the absence of evidence indicating that the risks of using Seroxat in adults outweigh the benefits, it would be difficult to justify withdrawing the medicine from use. The Yellow Card Scheme is recognised to be one of the best in the world in terms of the level of reporting, has a proven track record of identifying new drug safety hazards and enables the monitoring of all medicines, including Seroxat, in clinical use. The effectiveness of the Scheme is under continuous review by the Medicines and Healthcare products Regulatory Agency and the CSM. From April 2003, the first phase of patient reporting of suspected adverse drug reactions via NHS Direct was introduced. When fully rolled out in England and Wales, this will enable the first hand experiences of patients to be utilised in the identification and assessment of drug safety issues. Other measures to further strengthen the Yellow Card Scheme include a new regional monitoring centre, established in Scotland last year and the inclusion of education on yellow card reporting in the training of nurse prescribers.

Date

20 June 2003

Reference

119777;119778;119779;119780; 407 c488-9W;407 c489-90W

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher